STRASS is a landmark trial and the authors deserve warm congratulations for completing a study of this scale in a rare disease. Its results are very important, but they also must be analyzed thoughtfully and taken in context.Several initial points: The primary endpoint was abdominal recurrence-free...

Absolutely.

Thank you @David Konieczkowski for pointing out the local control benefit shown in this trial and previous reports. Certainly, the treatment of patients with RPS needs to be individualized but when I make the assessment that preoperative radiation will have low morbidity in a certain case I tend to ...